Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (30)

2023

  1. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)

    Journal of hypertension, Vol. 41, Núm. 12, pp. 1874-2071

  2. Corrigendum to “Genetic interaction in the association between oxidative stress and diabetes in the Spanish population” [Free Radic. Biol. Med. 205 (2023) 62–68, (S0891584923004719), (10.1016/j.freeradbiomed.2023.05.030)]

    Free Radical Biology and Medicine

  3. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  4. Genetic interaction in the association between oxidative stress and diabetes in the Spanish population

    Free Radical Biology and Medicine, Vol. 205, pp. 62-68

  5. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

  6. High miR-126-3p levels associated with cardiovascular events in a general population

    European Journal of Internal Medicine, Vol. 113, pp. 49-56

  7. Neurohumoral and Autonomic Regulation of Blood Pressure

    Pediatric Hypertension: Fifth Edition (Springer International Publishing), pp. 3-19

  8. Persistence and determinants of blood pressure phenotypes according to office and ambulatory blood pressure measurements in youth

    Hypertension Research, Vol. 46, Núm. 5, pp. 1257-1266

  9. Rab3A/Rab27A System Silencing Ameliorates High Glucose-Induced Injury in Podocytes

    Biology, Vol. 12, Núm. 5

  10. Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations

    High Blood Pressure and Cardiovascular Prevention, Vol. 30, Núm. 2, pp. 109-121

  11. Towards a personalized health care using a divisive hierarchical clustering approach for comorbidity and the prediction of conditioned group risks

    Health Informatics Journal, Vol. 29, Núm. 4

2022

  1. COMBINED EXOSOMAL AND PLASMA NON-CODING RNA SIGNATURE ASSOCIATED WITH URINARY ALBUMIN EXCRETION IN HYPERTENSION

    Journal of hypertension, Vol. 40, pp. e82

  2. DECREASED URINARY LEVELS OF SIRT1 AS NON-INVASIVE BIOMARKER OF EARLY RENAL DAMAGE IN HYPERTENSION

    Journal of hypertension, Vol. 40, pp. e249

  3. Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community

    ESC Heart Failure, Vol. 9, Núm. 6, pp. 4230-4239

2021

  1. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  2. Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation

    Frontiers in Cardiovascular Medicine, Vol. 8

2020

  1. Repositioning of the global epicentre of non-optimal cholesterol

    Nature, Vol. 582, Núm. 7810, pp. 73-77

2019

  1. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

2018

  1. Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients

    Journal of Clinical Hypertension, Vol. 20, Núm. 2, pp. 356-365

  2. Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants

    International Journal of Epidemiology, Vol. 47, Núm. 3, pp. 872-883i